Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design

Ahmad Husein Alkaff, Mutiara Saragih, Shabrina Noor Imana, Mochammad Arfin Fardiansyah Nasution, Usman Sumo Friend Tambunan

Research output: Contribution to journalArticlepeer-review

Abstract

Epimutation by DNA Methyltransferase 1 (DNMT1), an epigenetic regulator enzyme, may lead to the proliferation of breast cancer. In this report, 168,686 natural products from the PubChem database were screened and modified by in silico method to acquire the potential inhibitor of DNMT1. The initial screening of PubChem natural products using Lipinski's and Veber's rules of three and toxic properties have resulted in 2601 fragment candidates. Four fragments from pharmacophore-based molecular docking simulation were modified by utilizing FragFP and the Lipinski's and Veber's rules of five, and resulted in 51,200 ligands. The toxicological screening collected 13,563 ligands for a series of pharmacophore-based molecular docking simulations to sort out the modified ligands, which had the better binding activity and interactions to DNMT1 compared to the standards, SAH, SAM, and SFG. This step resulted in five ligand candidates, namely C-7756, C-5769, C-1723, C-2129, and C-2140. The ADME-Tox properties prediction showed that the selected ligands are generally better than standards in terms of druglikeness, GI absorption, and oral bioavailability. C-7756 exhibited a stronger affinity to DNMT1 as well as better ADME-Tox properties compared to the other ligands.

Original languageEnglish
JournalMolecules (Basel, Switzerland)
Volume26
Issue number2
DOIs
Publication statusPublished - 13 Jan 2021

Keywords

  • dengue
  • envelope protein
  • fragment growing
  • molecular docking simulation
  • natural product

Fingerprint Dive into the research topics of 'Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design'. Together they form a unique fingerprint.

Cite this